Researchers at the University of Helsinki have found that metformin can activate certain immune cells, making them better at spotting and attacking cancer. The findings, published in the Journal for ...

A multidisciplinary clinical team led by Professor Bernat Soria from the Institute of Bioengineering at the Miguel Hernández ...

A multidisciplinary clinical team led by Professor Bernat Soria from the Institute of Bioengineering at the Miguel Hernández University of Elche (UMH, Spain) has developed a new method to deliver cell ...

The multicenter, open-label Phase 1 study will enroll up to 80 patients with advanced relapsed and/or refractory solid tumors (ClinicalTrials.gov Identifier: NCT06840886). The study’s primary ...

Importantly, fexofenadine was also shown to significantly enhance the antitumor efficacy of osimertinib in a drug-refractory NSCLC patient-derived tumor xenograft (PDX) model in mice, without inducing ...

Understanding treatment mechanisms and consistent imaging protocols are essential for accurate evaluation, especially in managing complex cases like liver cancer. Collaboration between radiologists ...

1 Department of Endocrinology, Diabetes and Metabolism and Division of Laboratory Research, University Hospital Essen, University Duisburg-Essen, Essen, Germany 2 Department of Nuclear Medicine, ...